StockData
PDS Biotechnology Corp logo

PDS Biotechnology Corp (PDSB) stock

PDSBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 0/30
$0.89−0.03 (-3.28%)

Close on Nov 17, 2026Market cap $50.03MP/E –Yield –

PDS Biotechnology price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

PDS Biotechnology's price to book ratio was 9.8× on Jul 31, 2026, against 2.2× a year earlier. Over the last 5 years it ranged from 1.6× to 15.5×, with a median of 3.9×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jul 31, 20269.8×+6.0
2025Dec 31, 20253.9×+1.2
2024Dec 31, 20242.7×−3.6
2023Dec 29, 20236.3×−1.7
2022Dec 30, 20228.0×+4.6
2021Dec 31, 20213.4×+1.9
2020Dec 31, 20201.5×+0.6
2019Dec 31, 20190.9×−9.6
2018Jan 31, 201810.5×+2.8
2017Dec 29, 20177.7×+0.3
2016Dec 30, 20167.4×–

More PDS Biotechnology figures

See a number that looks wrong?